Home-based intravenous treatment with reslizumab for severe asthma in the Netherlands

登录注册会员服务联系我们

Home-based intravenous treatment with reslizumab for severe asthma in the Netherlands – An evaluation

Published:2022-04 Issue: Volume:194 Page:106776
ISSN:0954-6111
Container-title:Respiratory Medicine
language:en
Short-container-title:Respiratory Medicine

Author:

Bendien S.A.^ORCID,van Leeuwen M.M.^ORCID,Lau H.S.,Ten Brinke A.,Visser L.E.^ORCID,de Koning E.M.^ORCID,Braunstahl G.J.^ORCID

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference14 articles.

1. Assessment of an accessorized pre-filled syringe for home-administered benralizumab in severe asthma;Ferguson;J. Asthma Allergy,2018

2. Usability of mepolizumab single-use prefilled autoinjector for patient self-administration;Bernstein;J. Asthma,2020

3. Monoclonal antibodies for severe asthma: pharmacokinetic profiles;Matera;Respir. Med.,2019

4. The use of intravenous versus subcutaneous monoclonal antibodies in the treatment of severe asthma: a review;Matucci;Respir. Res.,2018

5. Weight-adjusted intravenous reslizumab in severe asthma with inadequate response to fixed-dose subcutaneous mepolizumab;Mukherjee;Am. J. Respir. Crit. Care Med.,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of patient support programmes among patients with severe asthma treated with biological therapies: a systematic literature review and indirect treatment comparison;BMJ Open Respiratory Research;2024-05

2. Citizens’ perspectives on relocating care: a scoping review;BMC Health Services Research;2024-02-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP